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Abstract
The ongoing cryptococcosis outbreak on Vancouver Island, BC, Canada, is caused by two VGII sub-genotypes of the primary pathogen,
Cryptococcus gattii: VGIIa isolates predominate, whereas VGIIb isolates are rare. Although higher virulence of the VGIIa genotype has
been proposed, an unresolved key question is whether VGIIa isolates from other regions are also more virulent than VGIIb isolates.
We report the relationship between genotype and virulence for a global collection of C. gattii VGIIa and VGIIb isolates (from Australia,
Argentina, Brazil, Canada, Thailand and the USA). In vitro and in vivo virulence studies were conducted. At 37C, growth [at 18 h: 0.2
optical density (OD) difference, p 0.026; at 36 h: 0.6 OD difference, p 0.036) and mean melanin production (OD = 0.25 vs. OD = 0.15,
p 0.059] of VGIIa isolates was greater than that of VGIIb isolates. The inhibitory effect of high temperature on melanin production of
VGIIa isolates was less than that of VGIIb isolates (OD = 0.36 vs. OD = 0.69; p 0.001). Capsule production at 37C of VGIIa isolates
was less than that of VGIIb isolates. All VGIIa isolates were fertile, whereas only 17% of VGIIb isolates were fertile (p <0.001). In vivo
virulence studies using the BALB/c mice nasal inhalation model revealed that VGIIa isolates were more virulent than VGIIb isolates
(p <0.001) independent of their clinical (p 0.003) or environmental origin (p <0.001). This study established a clear association between
genotype and virulence of the primary fungal pathogen, C. gattii.
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Introduction
The basidiomycetous yeasts of the Cryptococcus neoformans/
Cryptococcus gattii species complex are the most common
cause of fatal fungal meningitis in humans and can also
cause infections in a wide range of mammals [1]. Two
species have been deﬁned: C. neoformans, an opportunistic
pathogen, and C. gattii, a primary pathogen [2]. Over the
years, several typing methods have been applied to investi-
gate the epidemiology of these pathogenic yeasts. Using
serotyping and molecular typing based on M13 ﬁngerprint-
ing, ampliﬁed fragment length polymorphism (AFLP) analysis
and, more recently, multi-locus sequence typing (MLST)
using seven unlinked genetic loci (CAP59, GPD1, LAC1,
PLB1, SOD1, URA5 and IGS1), four serotypes and eight
molecular types have been recognized (C. neoformans: sero-
type A/molecular types VNI-VNII/AFLP1, D/VNIV/AFLP2,
hybrid AD/VNIII/AFLP3; C. gattii: B or C/VGI-IV/AFLP4-7)
[3–5]. In addition, interspecies hybrids between serotype B
and D have been reported (VNIV and VGI/AFLP2 and
AFLP4) [6].
In the microbial world, associations between biotype/
genotype and virulence are becoming better characterized.
For example, in bacteria, a correlation between the phylo-
genetic group B1 and Shiga toxin-producing Escherichia coli
has been reported [7]. In the case of pathogenic fungi, an
epidemiological survey of Candida albicans found a possible
association between a speciﬁc MLST clade and disease at
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speciﬁc human body sites [8]. However, a direct association
between virulence and genotype has never been reported
for any medical fungus. In an initial investigation of the cryp-
tococcosis outbreak on Vancouver Island, BC, Canada, it
was proposed that the major genotype (VGIIa) was signiﬁ-
cantly more virulent than the minor genotype (VGIIb), based
on virulence studies conducted on a single strain of each
genotype [9]. A more recent study by Ma et al. [10] has
emphasized and extended this ﬁnding by comparing ﬁve
North American (three from Vancouver Island, BC, Canada,
and two from the west coast of the USA) and one Carib-
bean VGIIa isolate and a single Canadian VGIIb isolate to a
global selection of strains representing different major
molecular types of the C. neoformans/C. gattii species com-
plex [10]. However, differences in virulence between the
two Vancouver Island outbreak genotypes (VGIIa vs. VGIIb)
have never been proven systematically using a range of iso-
lates of these genotypes on a global scale. Taking into
account the current high human mobility and the associated
risk of a spread of human fungal pathogens, it is of critical
importance to correlate genotype and virulence on a global
scale to predict potential outbreaks and initiate appropriate
public health responses [11]. For this reason, we investi-
gated the association between speciﬁc genotypes and viru-
lence based on in vitro and in vivo assays using a global
selection of VGIIa and VGIIb isolates. The results obtained
showed that VGIIa isolates were more virulent than
VGIIb isolates, irrespective of their geographic, clinical or
environmental origin.
Materials and Methods
Isolates and growth conditions
Twenty-one C. gattii VGIIa and VGIIb mating type a isolates
obtained from Australia, Argentina, Brazil, Canada, Thailand
and the USA, as well as the isolate B4546 (clinical VGIII
mating type a, used as an opposite mating type strain) from
the USA [12], were retrieved from the freeze-dried culture
collection of the Molecular Mycology Research Laboratory,
Westmead Hospital (Table 1). The original Vancouver Island
outbreak strains R265 (VGIIa) and R272 (VGIIb) [9] have
been used as reference strains in this study. The molecular
types were identiﬁed by PCR ﬁngerprinting [4], AFLP analysis
[13] and MLST [3]. Each isolate was initially grown on YPD
agar (2% glucose, 2% peptone, 1% yeast extract, 2% agar) at
30C and then subjected to the studies described below. For
the experiments using certain CFU/mL as starting points, the
C. gattii isolates were initially grown for 24 h in YPD broth
at 30C, washed twice with phosphate buffered saline
(3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM
NaCl, pH 7.4) and subjected to subsequent studies.
In vitro virulence study
To determine the virulence of all isolates, we selected: (i)
growth at 37C; (ii) melanin synthesis; and (iii) capsule size
from the set of established cryptococcal virulence factors.
All in vitro virulence studies were presented as average values
for either the VGIIa or VGIIb isolates studied.
TABLE 1. List of isolates and strain characteristics used in the present study
Name Country Source
Mating
type
Major molecular
type/genotype
Median days
of survival Fertility Reference
R265a Canada Clinical a VGIIa/AFLP6A 31 Fertile [13]
F3179 Canada Clinical a VGIIa/AFLP6A 29 Fertile [13]
RB39 Canada Environment a VGIIa/AFLP6A 29 Fertile [13]
RB45 Canada Environment a VGIIa/AFLP6A 29 Fertile [13]
RB59 Canada Environment a VGIIa/AFLP6A 32 Fertile [13]
CBS7750 USA Environment a VGIIa/AFLP6A >50 Fertile [32]
NIH444 USA Clinical a VGIIa/AFLP6A 46 Fertile [33]
F1623 Brazil/Japanb Clinical a VGIIa/AFLP6A 40 Fertile [15]
LA295 Argentina Clinical a VGIIa/AFLP6A 26 Fertile [4]
R272a Canada Clinical a VGIIb/AFLP6B >50 Fertile [13]
RB28 Canada Environment a VGIIb/AFLP6B >50 Infertile [13]
RB31 Canada Environment a VGIIb/AFLP6B >50 Infertile [13]
ARN001 Australia Environment a VGIIb/AFLP6B >50 Infertile [34]
RAM002 Australia Environment a VGIIb/AFLP6B >50 Infertile [34]
RAM005 Australia Environment a VGIIb/AFLP6B >50 Infertile [34]
RAM015 Australia Environment a VGIIb/AFLP6B >50 Infertile [34]
McBride Australia Veterinary a VGIIb/AFLP6B >50 Infertile [21]
Bandiaga Australia Clinical a VGIIb/AFLP6B 33 Infertile [34]
DMST20765 Thailand Clinical a VGIIb/AFLP6B >50 Infertile [35]
DMST20767 Thailand Clinical a VGIIb/AFLP6B 36 Infertile [35]
47-5061 Thailand Clinical a VGIIb/AFLP6B 40 Fertile [36]
B4546c USA Clinical a VGIII/AFLP5 NA Fertile [12]
NA, not applicable; N, infertile; F, fertile.
aOriginally studied virulent VGIIa and avirulent VGIIb strains [9].
bA Brazilian person living in Japan.
cVGIII mating type a strain.
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Growth test at 37C
Each isolate suspension was adjusted to an optical density
(OD) of 0.01 (approximately 105 CFU/mL) with 2% glucose
YNB and incubated at 37C. Cell density was determined by
spectrophotometry using the OD600 at 0, 18, 36 and 72 h.
Melanin synthesis test
Melanin production was quantiﬁed as described previously
[14,15]. Supernatants of the cultures were taken at 48 h and
their OD at 475 nm was measured. To eliminate growth
bias, the cell concentration was determined at 48 h and used
to normalize the OD.
Capsule production test
Capsule formation of each isolate was induced under the fol-
lowing capsule-inducing condition: Roswell Park Memorial
Institute Media # 1640 (RPMI-1640) with MOPS, HCO3, pH
7.3, in 5% CO2 at 37C, as described previously [16]. The
capsule size of at least 30 yeast cells per studied isolate was
measured by light microscopy using the diameter ratio of cap-
sule to capsule : cell wall to cell wall boundary of each cell.
Mating test
Mating assays with the opposite mating type, using strain
B4546 (clinical, VGIII, MATa) [12], were carried out on V8
medium [5% (v/v) V8 juice, 2 mM KH2PO4, 4% (w/v) agar] at
room temperature in darkness as described previously [17].
In vivo virulence study
Animal virulence studies were conducted with a total of nine
VGIIa and twelve VGIIb isolates (Table 1). For each isolate,
groups of ﬁve immunocompetent female BALB/c mice aged
6 weeks, 18–20 g, (Animal Resources Center, WA, Australia)
were infected intranasally with 105 cryptococcal cells as
described previously [9].
Statistical analysis
All statistical analyses, including the t-test, chi-square test and
Kaplan–Meier survival test, were conducted using SPSS, ver-
sion 15.0 (SPSS Inc., Chicago, IL, USA) and blotted using
GRAPHPAD PRISM version 5.0b (GraphPad Software Inc.,
San Diego, CA, USA). p <0.05 was considered statistically
signiﬁcant.
Results
Strain characteristics
Of the 21 C. gattii VGII isolates studied, nine were genotype
VGIIa and 12 isolates were VGIIb. The VGIIa isolates origi-
nated from Argentina, Canada, Brazil, Japan and the USA.
The VGIIb isolates originated from Australia, Canada and
Thailand. Both VGIIa and VGIIb isolates were only obtained
together from the same location from Vancouver Island,
Canada (Table 1). Within either the VGIIa or VGIIb geno-
type, all isolates studied to date had M13 PCR ﬁngerprinting
and AFLP patterns (Table 1), as well as MLST types identical
to those of the reference stains R265 (VGIIa) and R272
(VGIIb), respectively (ST20 for the VGIIa isolates with Gen-
Bank accession no. CAP59-GU079812; GPD1-GU079844;
IGS1-GU079875; LAC1-GU079906; PLB1-GU079694; SOD1-
GU079725; URA5-GU079768; and ST7 for the VGIIb
isolates with GenBank accession no. CAP59-GU079817;
GPD1-GU079849; IGS1-GU079880; LAC1-GU079911; PLB1-
GU079699; SOD1-GU079730; URA5-GU079773).
In vitro phenotypic studies
To deﬁne a correlation between genotype and virulence
characteristics of the C. gattii VGII isolates, the ability to
express the major cryptococcal virulence factors, growth at
human body temperature (37C), melanin synthesis and cap-
sule production, as well as the mating potential, were all
compared.
Growth at 37C
Because of large variation of the starting time point of the
log phase among isolates, which ranged from <18 h to over
36 h (data not shown), comparing the doubling time, which
is traditionally taken only from log phase data, would be con-
sidered inappropriate.
Thus, we compared the overall growth of each isolate
based on the fact that concentrations (OD600) of all isolates
were equal at time point zero. The VGIIa genotype pos-
sessed a greater ability to grow at 37C in 2% glucose YNB
as measured at 18 and 36 h (at 18 h: 0.2 OD difference,
p 0.026; at 36 h: 0.6 OD difference, p 0.036) (Fig. 1).
Growth difference at 72 h was not statistically signiﬁcant
(p 0.057).
Melanin synthesis
At 30C, VGIIa isolates produced less melanin than the
VGIIb isolates (VGIIa OD = 0.61, VGIIb OD = 0.84;
p 0.035). Because melanin synthesis might be inhibited at
human physiological temperature [18], we also performed
the melanin quantiﬁcation at 37C.
Interestingly, the opposite ﬁnding was observed at mam-
malian body temperature. Despite weak statistical support
(VGIIa OD = 0.25, VGIIb OD = 0.15; p 0.059) for the differ-
ence in melanin production between the two genotypes, an
inhibitory effect of 37C on melanin production by VGIIa iso-
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lates was less than that on melanin production by VGIIb iso-
lates (VGIIa OD = 0.36, VGIIb OD = 0.69; p 0.001) (Fig. 2).
Capsule production
Under capsule-inducing conditions, RPMI with MOPS, HCO3
(pH 7.3) in 5% CO2 at 37C [19], the VGIIa isolates
produced a smaller capsule (capsule–capsule : cell wall–cell
wall = 2.3) than the VGIIb isolates (capsule–capsule : cell
wall–cell wall = 2.6) (p <0.001) (Fig. 3).
Fertility
All nine VGIIa but only two of the 12 VGIIb isolates were
fertile (p <0.001; Table 1). This suggests that the VGIIa geno-
type has a higher intrinsic ability to undergo sexual repro-
duction than the VGIIb genotype. There was no difference in
the morphology of the teleomorphs between the fertile
strains of both genotypes. All fertile isolates of both geno-
types produced classical bacillus-shaped basidiospores.
In vivo virulence studies
Overall, VGIIa isolates showed greater virulence than the
VGIIb isolates (p <0.001; Fig. 4a–d). As in the immunocom-
promised mice model used previously [9], the VGIIb strain
R272 demonstrated a much lower virulence in the immuno-
competent mice model used. This ﬁnding was mirrored by
the majority of the other VGIIb isolates investigated (Fig. 4d,
Table 1). Interestingly, variations in virulence were observed
for all investigated isolates (Fig. 4c,d, Table 1) despite the
fact that all VGIIa and VGIIb isolates within each group had
identical molecular genotypes (data not shown). Clinical and
environmental VGIIa isolates (Fig. 4b) were more virulent
than clinical and environmental VGIIb isolates (p 0.003 and
p <0.001, respectively) (Fig. 4b). For both genotypes, the vir-
ulence of clinical isolates was higher than that of environ-
mental isolates, although the difference was only signiﬁcant
for the VGIIb group (p 0.110 for VGIIa isolates; p <0.001 for
VGIIb isolates) (Fig. 4c,d).
FIG. 2. Graph showing the average melanin production using dopa-
mine as a substrate of nine VGIIa and 12 VGIIb isolates. At 48 h,
VGIIa isolates produced less melanin at 30C (p 0.035), but more
melanin at 37C (p 0.059) (error bars ± SE = 2 SE). OD, optical
density.
FIG. 3. Capsule size examples of VGIIa and VGIIb isolates and graph
representing the average capsule–capsule : cell wall–cell wall ratio of
the nine VGIIa isolates and 12 VGIIb isolates showing that the cap-
sule size of VGIIa is less than that of the VGIIb isolates (·400,
p <0.001) (error bars = 2 SE).
FIG. 1. Average growth rates at 37C in 2% glucose YNB of nine
VGIIa and 12 VGIIb isolates (error bars ± SE = 2 SE). OD, optical
density.
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Discussion
The ﬁrst extensive outbreak of C. gattii infection occurred in
healthy human hosts and a variety of animals on Vancouver
Island, BC, Canada, a temperate climatic region [9,13]. Ear-
lier documented outbreaks occurred in goats in Spain [20]
and sheep in Western Australia [21]. These outbreaks have
emphasized the importance of understanding the epidemiol-
ogy, pathogenesis and virulence of the primary pathogen,
C. gattii.
Intensive epidemiological screening on Vancouver Island
and surrounding areas has revealed that approximately 90%
of all recovered isolates belonged to the VGIIa genotype,
with only approximately 10% belonging to the VGIIb geno-
type [9,13]. The predominance of the VGIIa genotype raised
the possibility that it has a higher level of ‘ecological ﬁtness’
than the VGIIb genotype, in addition to being more virulent
in mammalian hosts. Indeed, comparative virulence studies in
immunosuppressed A/Jcr mice showed that a representative
clinical isolate of the major genotype (strain R265) was more
virulent than a representative isolate of the minor genotype
(strain R272) [9].
This initial ﬁnding raised two major questions. First, was
the use of an immunocompromised mice model appropriate
for this primary pathogen, which normally causes diseases in
immunocompetent hosts? Second, do the results obtained
from a single isolate each of the VGIIa and the VGIIb type
represent the virulence potential of a representative collec-
tion of VGIIa and VGIIb isolates from around the world?
To answer these questions, we investigated and compared
the in vitro and in vivo virulence of VGIIa and VGIIb isolates
from global sources. The fact that all studied VGIIa isolates
possessed a greater ability to grow and produce melanin at
the human physiological temperature than the VGIIb isolates
(Figs 1 and 2) suggests that the high tolerance to this tem-
perature is a key feature for increased virulence. This is sup-
ported by the higher inhibitory effect of 37C on melanin
FIG. 4. Murine inhalation model using immunocompetent BALB/c mice. (a) Showing that the VGIIa genotype was more virulent than the VGIIb
genotype (p <0.001). (b) Showing the higher virulence of the VGIIa genotype in either a clinical (p 0.003*) or environmental (p <0.001) back-
ground. *The veterinary strain McBride was excluded from this analysis because only one veterinary isolate was studied. (c) Individual survival
curves for each of the VGIIa isolates studied. (d) Individual survival curves for each of the VGIIb isolates studied. Continuous lines represent
VGIIa isolates and dotted lines represent VGIIb isolates in (a) and (b). Continuous lines represent clinical isolates and dotted lines represent
environmental isolates in (c) and (d).
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production of the VGIIb isolates. In addition, the smaller
polysaccharide capsule size observed for VGIIa strains
(Fig. 3) reﬂects a ﬁnding of an earlier study, showing in vitro
evidence for a relationship between capsule size and viru-
lence [22]. Finally, the high fertility of the VGIIa isolates is
consistent with the unusually high levels of asexually pro-
duced basidiospores or blastoconidia in the environment of
Vancouver Island, where most isolates obtained via air sam-
pling belonged to the VGIIa genotype [13]. This in turn pro-
vides more infectious propagules, leading to a higher
exposure and, ultimately, to a higher infection rate.
In addition to the aforementioned differences in in vitro
virulence features, VGIIa isolates were in general more viru-
lent in vivo than VGIIb isolates (p <0.001) in the murine inha-
lation model using immunocompetent female BALB/c mice.
This conﬁrmed the previous suggestion, using immunocom-
promised A/Jcr mice and only one isolate per VGIIa and
VGIIb genotype [9], that the VGIIa genotype is more virulent
and showed that this observation is true for a representative
range of VGIIa isolates (Fig. 4, Table 1). It also conﬁrms the
ﬁndings of a later study that emphasized the higher virulence
of ﬁve North American VGIIa isolates in comparison with
isolates from the other major molecular types of the C. neo-
formans/C. gattii species complex, whereas, again, only the
reference VGIIb isolate (R272) was tested [10]. Further-
more, the higher virulence of clinical isolates of both sub-
genotypes compared to the environmental isolates is in
agreement with recently published data on isolates of the
molecular type VNI of the closely related species C. neofor-
mans var. grubii, which showed that clinical isolates were
more virulent than environmental isolates using an identical
model [23]. They disagree, however, with a previous report
reporting greater virulence of environmental isolates of
C. gattii [24]. This discrepancy is perhaps the result of only
six isolates being tested and the molecular types not being
determined [24]. Interestingly, one of those strains, a viru-
lent strain (B4534) in the original studies [24] is the same
strain as CBS7750 [25], which showed a low virulence in
our study as well as in a recent study by Ma et al. [10] using
intranasal or tail vein injection, respectively. The difference
in virulence observed in our study could be a result of the
different route of infection, implying that lung protection is
an important factor for preventing cryptococcosis, although
the pulmonary immune response is known to be suppressed
by C. gattii [26]. However, Ma et al. [10] used the same
route of infection (i.e. intravenous injection) in albino male
BALB/c mice of 20–23 g weight, instead of female BALB/c
mice of 19–20 g weight, as employed in the original studies
by Kwon-Chung et al. [24], but also showed that the strain
CBS7750 is a low virulent strain. This may either reﬂect a
different susceptibility to the infection of the mouse strain
used or indicate that this speciﬁc cryptococcal strain has lost
its original virulence as a result of long-term sub-culturing, as
was also observed for other cryptococcal strains [27]. Con-
tradicting results obtained from different sets of isolates sug-
gest that the virulence of environmental isolates of different
molecular types may differ to a certain extent. Clearly, an
extensive virulence survey of additional clinical and environ-
mental C. gattii isolates representing all molecular types is
warranted.
In addition to the differences in virulence observed
between VGIIa and VGIIb isolates in general and between
clinical/environmental isolates of both genotypes speciﬁcally,
variations in the virulence of individual isolates were
observed despite the fact that all isolates within each of the
two genotypes had identical M13 PCR ﬁngerprints, AFLP
proﬁles [13] and MLST sequence types (ST20 or ST7,
respectively), an observation that had also been reported in
a study of the virulence of C. neoformans var. grubii VNI iso-
lates [23]. Taken together, these ﬁndings emphasize that sev-
eral isolates per genotype must be tested before any
conclusion can be drawing concerning the virulence of a spe-
cies, molecular type or genotype within the C. neoformans/
C. gattii species complex.
Genotype and virulence have been correlated in a number
of pathogenic microorganisms [7,28], including a limited num-
ber of C. gattii strains [3,10]. This is the ﬁrst study to establish
a correlation between speciﬁc genotypes and virulence for a
large number of globally collected VGIIa and VGIIb strains.
Although lethal fungal infections are not as frequent as viral
and bacterial infections and are mostly limited to immunocom-
promised patients, small outbreaks of mycoses have periodi-
cally emerged in several parts of the world [29–31]. Increasing
human mobility and the increasing number of global reports of
fungal infection emphasize the need for more surveillance
regarding ‘hidden’ potentially highly pathogenic fungal geno-
types. Determination of speciﬁc genotypes and their correla-
tions with virulence is a vital epidemiological tool for precise
and efﬁcient surveillance. Such knowledge is a prerequisite for
an appropriate and timely response to newly emerging and
highly pathogenic genotypes, in an effort to effectively con-
strain or even prevent phenomena such as the ongoing crypto-
coccosis outbreak on Vancouver Island, Canada, or elsewhere.
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